CVS Health® (NYSE: CVS) is actively supporting its customers, members, provider partners and colleagues as they respond to the California wildfires. The company prioritizes the health and safety of ...
As many as 10 family-owned or pharmacies faced closure each day around the United States of America in 2024. This isnât due ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...
The U.S. district judge in Cleveland, Ohio handling a galaxy of claims stemming from the prescription opioid epidemic on ...
A state law that went into effect this week aims to regulate the role of third-party pharmacy benefit managers, who many say are inflating drug costs.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...
In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on CVS Health (CVS – Research Report), with a price target of ...
Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...
Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback